Potential Impact of miR-137 and Its Targets in Schizophrenia.
about
Noncoding RNAs and neurobehavioral mechanisms in psychiatric diseaseE Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and DiseaseAssociation of a miRNA-137 polymorphism with schizophrenia in a Southern Chinese Han population.Heterogeneity and individuality: microRNAs in mental disorders.Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysisNo effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure.Converging evidence implicates the abnormal microRNA system in schizophreniaMeta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia riskHigh Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia.Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia.Transcriptome study of differential expression in schizophrenia.MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients.miR-137: a new player in schizophrenia.Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells.Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.Integrating the roles of long and small non-coding RNA in brain function and disease.Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia.Recent genetic findings in schizophrenia and their therapeutic relevanceMicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.Kraepelin revisited: schizophrenia from degeneration to failed regeneration.The schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function.miR-124, -128, and -137 Orchestrate Neural Differentiation by Acting on Overlapping Gene Sets Containing a Highly Connected Transcription Factor Network.KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.MiR-137: an important player in neural development and neoplastic transformation.MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets.MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls.MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia.Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci.Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation.Allelic imbalance associated with the schizophrenia risk SNP rs1344706 indicates a cis-acting variant in ZNF804A.Small RNAs May Answer Big Questions in Mental Illness.A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen.A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.The Multifarious Hippocampal Functions of MicroRNA-137.MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission.Association of With Symptom Severity and Cognitive Functioning in Belarusian Schizophrenia Patients
P2860
Q26851626-D7321F2E-CBAD-4DCF-B603-BA37121E0C2BQ30054095-8D66C7CE-439B-40C6-82A6-D7A7EB68BF0BQ34177537-61A3B2E8-3FDE-4BE6-BCEE-51A4A2BAD8CEQ34447816-BA8D6306-5F83-4B28-B196-40345356D5C8Q34458640-B6500DFF-0C83-4103-ADFD-BFB0AF6F8BADQ34578760-E19B2D8E-4908-4DD9-B612-AF00662D4D34Q35369767-5B350337-E371-4C43-A163-4C90840423DDQ35489742-1BF84BC0-BDDC-421D-8A88-E41A5473204FQ35771016-2273F141-190B-4FF9-9FD5-C82594961533Q35940904-53A42AE1-2E01-45FD-93CF-2B78335A71DDQ36915423-218E421F-61B5-49D9-BFEA-0E49DD76D709Q37332227-BDFE92AE-179E-4859-84C5-0090802F76D1Q37363559-FB0AB8BF-3B43-4F74-974E-C0A09356D800Q37645440-C70B73A6-4353-4948-80EB-C398CD1FC430Q37706529-7019EBDE-26CF-4986-B3FE-500D9CD5FD1BQ38177652-B10C3C41-B504-40C6-9263-4339B41E4AAEQ38182329-DAD38370-9BB2-449C-AD2F-40B8B40AD33BQ38189850-76B06893-62B2-4C12-BC2F-8D8661956AFCQ38191819-BD3DD5C4-5979-4F85-BC14-28CA9EB63E74Q38260258-8A9AF337-B970-4A47-945B-FA14E39E36C9Q38267957-C1D1F2DF-06FE-4960-8240-251848884B3AQ38396447-A48204E7-B184-4E0A-83EA-7146C102D1A5Q38450466-1D263339-4694-424F-BD15-B2B3F945466CQ38457838-8C84D4CC-838C-46A8-8E1D-96A4C7BEE650Q38537765-FE4805B8-D73B-4A0B-A803-3B9C76917B57Q38952716-9D3F6BBE-C898-4417-B801-F9725FFCA68CQ38989183-F9E65296-EAC2-427B-B3C6-F2B02176C510Q39002120-9980FFD1-147C-452B-9195-C4E0F3B42770Q39185826-4CCA0CA5-921D-411A-8684-F0E71811654BQ40084576-887534DB-858B-4CFC-89B7-2DE6E65AAC0FQ40437176-F1A5784C-5B91-40C4-A4DD-F5CB19AF4711Q42507566-A62BA339-41E5-4624-995E-352C83086714Q47112089-3EA872E8-1636-4045-9E49-31AB10DE541AQ47782721-6FE3AEDD-966D-4650-B610-713E1871C86FQ50015658-4C609A6C-ED07-48A9-A721-BC4A68C55CBBQ52148949-239B9377-6F12-4379-BD68-3BCA9BB78FDCQ52326263-2E642721-2057-4A5F-B37C-EEBF9ACD2A70Q57945283-E7327876-84E8-4F23-8237-D8FFDB108C50
P2860
Potential Impact of miR-137 and Its Targets in Schizophrenia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Potential Impact of miR-137 and Its Targets in Schizophrenia.
@ast
Potential Impact of miR-137 and Its Targets in Schizophrenia.
@en
type
label
Potential Impact of miR-137 and Its Targets in Schizophrenia.
@ast
Potential Impact of miR-137 and Its Targets in Schizophrenia.
@en
prefLabel
Potential Impact of miR-137 and Its Targets in Schizophrenia.
@ast
Potential Impact of miR-137 and Its Targets in Schizophrenia.
@en
P2860
P50
P356
P1476
Potential Impact of miR-137 and Its Targets in Schizophrenia.
@en
P2093
Nora Perrone-Bizzozero
P2860
P356
10.3389/FGENE.2013.00058
P577
2013-04-26T00:00:00Z